Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 853 | 623 | 42 | 1,342 | 1,809 |
| Cost of Goods | 678 | 502 | 29 | 1,073 | 1,447 |
| Gross Profit | 175 | 120 | 13 | 268 | 362 |
| Operating Expenses | 5,931 | 5,133 | 5,403 | 6,009 | 4,829 |
| Operating Income | -5,078 | -4,511 | -5,361 | -5,667 | -4,020 |
| Interest Expense | 96 | 96 | 93 | 95 | 32 |
| Other Income | 235 | 302 | 383 | 343 | 138 |
| Pre-tax Income | -4,939 | -4,304 | -5,071 | -5,419 | -3,914 |
| Net Income Continuous | -4,939 | -4,304 | -5,071 | -5,419 | -3,914 |
| Net Income | $-4,939 | $-4,304 | $-5,071 | $-5,419 | $-3,914 |
| EPS Basic Total Ops | -5.60 | -4.80 | -5.60 | -6.00 | -4.40 |
| EPS Basic Continuous Ops | -5.50 | -4.79 | -5.65 | -6.05 | -4.37 |
| EPS Diluted Total Ops | -5.60 | -4.80 | -5.60 | -6.00 | -4.40 |
| EPS Diluted Continuous Ops | -5.50 | -4.79 | -5.65 | -6.05 | -4.37 |
| EBITDA(a) | $-4,800 | $-4,226 | $-5,062 | $-5,406 | $-3,855 |